GNRH1 and endometriosis: This recommendation is supported by data from a prospective, non-randomized trial of women with chronic pelvic pain associated with recurrent endometriosis, who achieved pelvic pain relief after 4–6 months of treatment with a GnRH agonist followed by 12 months of therapy with dienogest (1–2 mg/day) [84].